The world’s newest anti-viral treatment for Covid-19, Sotrovimab, is now available for early treatment of certain categories Covid-19 patients in the UAE following a landmark agreement between the Abu Dhabi Department of Health, the country’s leading group purchasing organization (GPO) Rafed, and global innovative biopharmaceutical company GlaxoSmithKline (GSK). With the arrival of the first shipment in Abu Dhabi airport, Abu Dhabi become the first city globally to receive this drug.